USAC Stock Analysis: USA Compression | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 3.821m USD | 12M Return: 16.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.65M
EPS Trend: 87.5%
Qual. Beats: -1
Rev. Trend: 97.6%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
USA Compression Partners, LP (NYSE: USAC) is a U.S.-based provider of natural gas compression services, primarily serving oil and gas producers, processors, gatherers, and transporters. The company also operates equipment for natural gas treating, including carbon dioxide and hydrogen sulfide removal, cooling, and dehydration, serving both producers and midstream customers. As of December 31, 2025, the companys fleet totaled 3.9 million horsepower, and it is headquartered in Dallas, Texas.
The company operates within the midstream segment of the energy value chain, which focuses on the gathering, processing, and transportation of hydrocarbons between production sites and end markets. Compression services are typically delivered under long-term, fee-based contracts, providing relatively stable revenue tied to horsepower commitments rather than commodity prices. USAC is structured as a Master Limited Partnership (MLP), a common entity type in the midstream sector that passes income through to unit holders.
Founded in 1998 and publicly listed since January 2013, USAC trades as a mid-cap stock in the Energy sector. Customer demand for compression services is driven largely by U.S. natural gas production volumes, gathering system expansion, and gas lift applications in crude oil wells.
- Natural gas production growth drives compression fleet utilization higher
- Fleet horsepower expansion supports contract revenue growth
- Interest rate cuts reduce MLP debt servicing costs
| Net Income: 129.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: 11.31% < 20% (prev 7.99%; Δ 3.32% < -1%) |
| CFO/TA 0.11 > 3% & CFO 425.7m > Net Income 129.1m |
| Net Debt (2.99b) to EBITDA (630.9m): 4.74 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.1m) vs 12m ago 21.04% < -2% |
| Gross Margin: 51.61% > 18% (prev 67.38%; Δ -15.76% > 0.5%) |
| Asset Turnover: 33.63% > 50% (prev 35.62%; Δ -1.99% > 0%) |
| Interest Coverage Ratio: 1.74 > 6 (EBIT TTM 329.3m / Interest Expense TTM 189.0m) |
| DSRI: 1.49 (Receivables 162.9m/97.4m, Revenue 1.08b/966.4m) |
| GMI: 1.31 (GM 67.38% / 51.61%) |
| AQI: 1.07 (AQ_t 0.09 / AQ_t-1 0.08) |
| SGI: 1.12 (Revenue 1.08b / 966.4m) |
| TATA: -0.08 (NI 129.1m - CFO 425.7m) / TA 3.73b) |
| Beneish M = -2.22 (Cap -4..+1) = BBB |
As of July 14, 2026, the stock is trading at USD 26.48 with a total of 48,860 shares traded. Over the past week, the price has changed by +0.46%, over one month by -0.94%, over three months by -1.94% and over the past year by +16.63%.
Current recommended Stop Loss: 25.20 (which is 4.8% or 1.4 ATR below the current price).
USA Compression has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold USAC.
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 29.7 | 12% |
P/E Trailing = 26.898
P/E Forward = 23.5294
P/S = 3.5249
P/B = 12.0678
P/EG = -68.32
Revenue TTM = 1.08b USD
EBIT TTM = 329.3m USD
EBITDA TTM = 630.9m USD
Long Term Debt = 2.98b USD (from longTermDebt, last quarter)
Short Term Debt = 4.82m USD (from shortTermDebt, last fiscal year)
Debt = 3.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 13.7m
Net Debt = 2.99b USD (calculated: Debt 3.01b - CCE 14.5m)
Enterprise Value = 6.81b USD (3.82b + Debt 3.01b - CCE 14.5m)
Interest Coverage Ratio = 1.74 (Ebit TTM 329.3m / Interest Expense TTM 189.0m)
EV/FCF = 22.52x (Enterprise Value 6.81b / FCF TTM 302.6m)
FCF Yield = 4.44% (FCF TTM 302.6m / Enterprise Value 6.81b)
FCF Margin = 27.91% (FCF TTM 302.6m / Revenue TTM 1.08b)
Net Margin = 11.91% (Net Income TTM 129.1m / Revenue TTM 1.08b)
Gross Margin = 51.61% ((Revenue TTM 1.08b - Cost of Revenue TTM 524.6m) / Revenue TTM)
Gross Margin QoQ = 38.10% (prev 38.18%)
Tobins Q-Ratio = 1.82 (Enterprise Value 6.81b / Total Assets 3.73b)
Interest Expense / Debt = 6.28% (Interest Expense 189.0m / Debt 3.01b)
Taxrate = 5.46% (7.46m / 136.6m)
NOPAT = 311.4m (EBIT 329.3m * (1 - 5.46%))
Current Ratio = 1.55 (Total Current Assets 346.8m / Total Current Liabilities 224.2m)
Debt / Equity = 9.50 (Debt 3.01b / totalStockholderEquity, last quarter 316.7m)
Debt / EBITDA = 4.74 (Net Debt 2.99b / EBITDA 630.9m)
Debt / FCF = 9.89 (Net Debt 2.99b / FCF TTM 302.6m)
Total Stockholder Equity = 19.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.01% (Net Income 129.1m / Total Assets 3.73b)
RoE = 651.1% (Net Income TTM 129.1m / Total Stockholder Equity 19.8m)
RoCE = 10.98% (EBIT 329.3m / Capital Employed (Equity 19.8m + L.T.Debt 2.98b))
RoIC = 8.90% (NOPAT 311.4m / Invested Capital 3.50b)
WACC = 6.80% (E(3.82b)/V(6.83b) * Re(7.47%) + D(3.01b)/V(6.83b) * Rd(6.28%) * (1-Tc(0.05)))
Discount Rate = 7.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 15.78%
[DCF] Terminal Value 77.97% ; FCFF base≈263.7m ; Y1≈302.3m ; Y5≈444.9m
[DCF] Fair Price = 25.54 (EV 6.70b - Net Debt 2.99b = Equity 3.70b / Shares 145.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 87.48 | EPS CAGR: 177.5% | SUE: -0.90 | # QB: -1
Revenue Correlation: 97.57 | Revenue CAGR: 10.99% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.33 | Chg30d=-1.64% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=-4.46% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=1.32 | Chg30d=-7.61% | Revisions=-40% | GrowthEPS=+30.1% | GrowthRev=+36.7%
EPS next Year (2027-12-31): EPS=1.79 | Chg30d=-0.42% | Revisions=+0% | GrowthEPS=+35.3% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -30% (up=2, down=5)